Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Abstract 1846: Enhancing chemoimmunotherapy of metastatic TNBC through potent and immunomodulatory drug combination nanoparticles

Caroline B. Linde, Xiaolin Xu, Rodney J. Ho, Mary L. Disis, Qingxin Mu

Cancer Res (2025) 85 (8_Supplement_1): 1846.

https://doi.org/10.1158/1538-7445.AM2025-1846

Published: 21 April 2025

View articletitled, Abstract 1846: Enhancing chemoimmunotherapy of metastatic TNBC through potent and immunomodulatory drug combination nanoparticles

Journal Articles

Abstract 4114: AST-201 (pUMVC3-hIGFBP2 N-terminus) demonstrates anti-tumor effect in an ovarian cancer mouse model

Jinback Lim, Jinho Kang, Hyo-Hyun Park, Jin Kyeong Choi, Jee Hyun Choi, Seong-Yong Jang, Min-Ah Kim, Myeong-Kyu Park, Mary L Disis, Eunkyo Joung, Ashley Yongmin Kim, Hun Jung

Cancer Res (2024) 84 (6_Supplement): 4114.

https://doi.org/10.1158/1538-7445.AM2024-4114

Published: 22 March 2024

View articletitled, Abstract 4114: AST-201 (pUMVC3-hIGFBP2 N-terminus) demonstrates anti-tumor effect in an ovarian cancer mouse model

Journal Articles

Abstract 6434: A precision probiotic therapeutic promotes a more efficacious type I immune response and limits breast cancer growth in mice

Denise L. Cecil, Erin Rodmaker, Susan Strenk, Lauren Corulli, David N. Fredricks, Mary L. Disis

Cancer Res (2023) 83 (7_Supplement): 6434.

https://doi.org/10.1158/1538-7445.AM2023-6434

Published: 04 April 2023

View articletitled, Abstract 6434: A precision probiotic therapeutic promotes a more efficacious type I immune response and limits breast cancer growth in mice

Journal Articles

Abstract 5112: Immune biomarkers of clinical response after NSAID treatment in combination with vaccination targeting EGFR-COX2-CDC25B in the APC(Min/+) mouse model

Denise L. Cecil, Ying Liu, Lauren Corulli, Mary L. Disis

Cancer Res (2023) 83 (7_Supplement): 5112.

https://doi.org/10.1158/1538-7445.AM2023-5112

Published: 04 April 2023

View articletitled, Abstract 5112: Immune biomarkers of clinical response after NSAID treatment in combination with vaccination targeting EGFR-COX2-CDC25B in the APC(Min/+) mouse model

Journal Articles

Abstract 3380: Seven autoantibody panel, validated in two independent patient serum collections, can detect women with DCIS and invasive breast cancer

Sasha Elizabeth Stanton, Jason Schlumbohm, Erik Ramos, Charles Drescher, Jeffrey Marks, Mary L. Disis

Cancer Res (2022) 82 (12_Supplement): 3380.

https://doi.org/10.1158/1538-7445.AM2022-3380

Published: 15 June 2022

View articletitled, Abstract 3380: Seven autoantibody panel, validated in two independent patient serum collections, can detect women with DCIS and invasive breast cancer

Journal Articles

Abstract 1556: Retinoid X receptor agonists enhances Th1 antigen-specific and polyfunctional T cells with the HER2-IGFBP2-IGF1R vaccine

Sasha Elizabeth Stanton, Erin Rodmaker, Nicholas Drovetto, Lauren Corulli, Flonia Levy, Venkatram Atigadda, Clinton Grubbs, Romaine Fernando, Shizuko Sei, Mary L. Disis

Cancer Res (2021) 81 (13_Supplement): 1556.

https://doi.org/10.1158/1538-7445.AM2021-1556

Published: 01 July 2021

View articletitled, Abstract 1556: Retinoid X receptor agonists enhances Th1 antigen-specific and polyfunctional T cells with the HER2-IGFBP2-IGF1R vaccine

Journal Articles

Abstract 6593: PRGN-3005 UltraCAR-T™: multigenic CAR-T cells generated using non-viral gene delivery and rapid manufacturing process for the treatment of ovarian cancer

Tim Chan, Marion Chakiath, Lindsey Shepard, Simon Metenou, Fernando Carvajal-Borda, Jose Velez, Adeline Govekung, Jacques Plummer, Carol Poortman, Padma Kamineny, Xiaohong Ma, Rutul R. Shah, Mary L. Disis, Helen Sabzevari

Cancer Res (2020) 80 (16_Supplement): 6593.

https://doi.org/10.1158/1538-7445.AM2020-6593

Published: 15 August 2020

View articletitled, Abstract 6593: PRGN-3005 UltraCAR-T™: multigenic CAR-T cells generated using non-viral gene delivery and rapid manufacturing process for the treatment of ovarian cancer

Journal Articles

Abstract 1184: Comprehensive analysis with interactive exploration of immune response signatures in 10,000 tumor samples

Vesteinn Thorsson, David L. Gibbs, Mary L. Disis, Elizabeth G. Demicco, Alexander J. Lazar, Jonathan S. Serody, James A. Eddy, Ilya Shmulevich, Justin Guinney, Benjamin G. Vincent

Cancer Res (2019) 79 (13_Supplement): 1184.

https://doi.org/10.1158/1538-7445.AM2019-1184

Published: 01 July 2019

View articletitled, Abstract 1184: Comprehensive analysis with interactive exploration of immune response signatures in 10,000 tumor samples

Journal Articles

Abstract 1266: Downregulation of PD-L1 by NSAID administration augments the effects of a multi-antigen vaccine for the prevention of adenomatous polyps in APC(Min/+) mice

Mary L. Disis, Lauren R. Corulli, Clinton Grubbs, Ronald A. Lubet, Paul Cowan, Ekram Gad

Cancer Res (2018) 78 (13_Supplement): 1266.

https://doi.org/10.1158/1538-7445.AM2018-1266

Published: 01 July 2018

View articletitled, Abstract 1266: Downregulation of PD-L1 by NSAID administration augments the effects of a multi-antigen vaccine for the prevention of adenomatous polyps in APC(Min/+) mice

Journal Articles

Abstract 2224: Panel of autoantibodies to seven early tumor-associated overexpressed proteins can identify women with DCIS from women with benign breast tumors detected by mammography

Sasha Elizabeth Stanton, Erik Ramos, Mary L. Disis

Cancer Res (2018) 78 (13_Supplement): 2224.

https://doi.org/10.1158/1538-7445.AM2018-2224

Published: 01 July 2018

View articletitled, Abstract 2224: Panel of autoantibodies to seven early tumor-associated overexpressed proteins can identify women with DCIS from women with benign breast tumors detected by mammography

Journal Articles

Abstract 623: Identifying candidate antigens for a ductal carcinoma in situ vaccine that are essential to breast cancer survival across multiple subtypes

Sasha Elizabeth Stanton, Erik Ramos, James Annis, Andrew Timms, Tessa Rue, Mary L. Disis

Cancer Res (2017) 77 (13_Supplement): 623.

https://doi.org/10.1158/1538-7445.AM2017-623

Published: 01 July 2017

View articletitled, Abstract 623: Identifying candidate antigens for a ductal carcinoma in situ vaccine that are essential to breast cancer survival across multiple subtypes

Journal Articles

Abstract 3687: Bexarotene activates type 1 antigen presenting cells, increases tumor infiltrating CD8 T-cells, and augments the anti-tumor activity of chemotherapy in breast cancer

Sasha Elizabeth Stanton, Ekram Gad, Lauren R. Corulli-Rastetter, Mary L. Disis

Cancer Res (2017) 77 (13_Supplement): 3687.

https://doi.org/10.1158/1538-7445.AM2017-3687

Published: 01 July 2017

View articletitled, Abstract 3687: Bexarotene activates type 1 antigen presenting cells, increases tumor infiltrating CD8 T-cells, and augments the anti-tumor activity of chemotherapy in breast cancer

Journal Articles

Precancer Atlas to Drive Precision Prevention Trials

Cancer Res (2017) 77 (7): 1510–1541.

https://doi.org/10.1158/0008-5472.CAN-16-2346

Published: 02 April 2017

View articletitled, Precancer Atlas to Drive Precision Prevention Trials

Journal Articles

An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis

Hiroyuki Katayama, Clayton Boldt, Jon J. Ladd, Melissa M. Johnson, Timothy Chao, Michela Capello, Jinfeng Suo, Jianning Mao, JoAnn E. Manson, Ross Prentice, Francisco Esteva, Hong Wang, Mary L. Disis, Samir Hanash

Cancer Res (2015) 75 (16): 3246–3254.

https://doi.org/10.1158/0008-5472.CAN-15-0248

Published: 13 August 2015

View articletitled, An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis

Journal Articles

Abstract 1352: Identifying pre-diagnostic breast cancer antigens in transgenic mouse mammary tumor models for preventative vaccine development

Sasha E. Stanton, Ekram Gadd, Lauren Rastetter, James Annis, Jianning Mao, John Ladd, Samir Hanash, Mary L. Disis

Cancer Res (2015) 75 (15_Supplement): 1352.

https://doi.org/10.1158/1538-7445.AM2015-1352

Published: 01 August 2015

View articletitled, Abstract 1352: Identifying pre-diagnostic breast cancer antigens in transgenic mouse mammary tumor models for preventative vaccine development

Journal Articles

Abstract 273: TLR8 agonist VTX-2337 (motolimod) decreases monocytic myeloid-derived suppressor cells by inducing differentiation to mature antigen-presenting cells

Zina J. Rutnam, Yushe Dang, Gregory Diestch, Hailing Lu, Yi Yang, Robert Hershberg, Mary L. Disis

Cancer Res (2015) 75 (15_Supplement): 273.

https://doi.org/10.1158/1538-7445.AM2015-273

Published: 01 August 2015

View articletitled, Abstract 273: TLR8 agonist VTX-2337 (motolimod) decreases monocytic myeloid-derived suppressor cells by inducing differentiation to mature antigen-presenting cells

Journal Articles

Abstract 279: Bexarotene increases tumor CD8+ T cells and improves response to conventional breast chemotherapy in the transgenic mouse mammary tumor model TgMMTV-neu

Sasha E. Stanton, Ekram Gadd, Edmond Marzbani, Lauren Rastetter, Mary L. Disis

Cancer Res (2015) 75 (15_Supplement): 279.

https://doi.org/10.1158/1538-7445.AM2015-279

Published: 01 August 2015

View articletitled, Abstract 279: Bexarotene increases tumor CD8+ T cells and improves response to conventional breast chemotherapy in the transgenic mouse mammary tumor model TgMMTV-neu

Journal Articles

Abstract 286: Coordinated activation of TLR8 and NLRP3 by VTX-2337 (motolimod) ignites tumoricidal NK cell activity

Greg Dietsch, Haling Lu, Yi Yang, Chihiro Morishima, Laura Q. Chow, Mary L. Disis, Robert Hershberg

Cancer Res (2015) 75 (15_Supplement): 286.

https://doi.org/10.1158/1538-7445.AM2015-286

Published: 01 August 2015

View articletitled, Abstract 286: Coordinated activation of TLR8 and NLRP3 by VTX-2337 (motolimod) ignites tumoricidal NK cell activity

Journal Articles

Abstract 3135: HER2 specific adoptive T cells shown to localize and infiltrate all sites of disease using combined SPECT and PET imaging

Sasha E. Stanton, Janet Eary, Edmond Marzbani, David Mankoff, Lupe Salazar, Doreen Higgins, Jessica Reichow, Yushe Dang, Mary L. Disis

Cancer Res (2015) 75 (15_Supplement): 3135.

https://doi.org/10.1158/1538-7445.AM2015-3135

Published: 01 August 2015

View articletitled, Abstract 3135: HER2 specific adoptive T cells shown to localize and infiltrate all sites of disease using combined SPECT and PET imaging

Journal Articles

Abstract ES6-1: Immunotherapeutic approaches to breast cancer

Mary L Disis

Cancer Res (2015) 75 (9_Supplement): ES6-1.

https://doi.org/10.1158/1538-7445.SABCS14-ES6-1

Published: 01 May 2015

View articletitled, Abstract ES6-1: Immunotherapeutic approaches to breast cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 1846: Enhancing chemoimmunotherapy of metastatic TNBC through potent and immunomodulatory drug combination nanoparticles

Abstract 4114: AST-201 (pUMVC3-hIGFBP2 N-terminus) demonstrates anti-tumor effect in an ovarian cancer mouse model

Abstract 6434: A precision probiotic therapeutic promotes a more efficacious type I immune response and limits breast cancer growth in mice

Abstract 5112: Immune biomarkers of clinical response after NSAID treatment in combination with vaccination targeting EGFR-COX2-CDC25B in the APC(Min/+) mouse model

Abstract 3380: Seven autoantibody panel, validated in two independent patient serum collections, can detect women with DCIS and invasive breast cancer

Abstract 1556: Retinoid X receptor agonists enhances Th1 antigen-specific and polyfunctional T cells with the HER2-IGFBP2-IGF1R vaccine

Abstract 6593: PRGN-3005 UltraCAR-T™: multigenic CAR-T cells generated using non-viral gene delivery and rapid manufacturing process for the treatment of ovarian cancer

Abstract 1184: Comprehensive analysis with interactive exploration of immune response signatures in 10,000 tumor samples

Abstract 1266: Downregulation of PD-L1 by NSAID administration augments the effects of a multi-antigen vaccine for the prevention of adenomatous polyps in APC(Min/+) mice

Abstract 2224: Panel of autoantibodies to seven early tumor-associated overexpressed proteins can identify women with DCIS from women with benign breast tumors detected by mammography

Abstract 623: Identifying candidate antigens for a ductal carcinoma in situ vaccine that are essential to breast cancer survival across multiple subtypes

Abstract 3687: Bexarotene activates type 1 antigen presenting cells, increases tumor infiltrating CD8 T-cells, and augments the anti-tumor activity of chemotherapy in breast cancer

Precancer Atlas to Drive Precision Prevention Trials

An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis

Abstract 1352: Identifying pre-diagnostic breast cancer antigens in transgenic mouse mammary tumor models for preventative vaccine development

Abstract 273: TLR8 agonist VTX-2337 (motolimod) decreases monocytic myeloid-derived suppressor cells by inducing differentiation to mature antigen-presenting cells

Abstract 279: Bexarotene increases tumor CD8+ T cells and improves response to conventional breast chemotherapy in the transgenic mouse mammary tumor model TgMMTV-neu

Abstract 286: Coordinated activation of TLR8 and NLRP3 by VTX-2337 (motolimod) ignites tumoricidal NK cell activity

Abstract 3135: HER2 specific adoptive T cells shown to localize and infiltrate all sites of disease using combined SPECT and PET imaging

Abstract ES6-1: Immunotherapeutic approaches to breast cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only